logo
#

Latest news with #PHM

PulteGroup (PHM) Snaps 3-Day Losses on Buy Reco, Higher Price Target
PulteGroup (PHM) Snaps 3-Day Losses on Buy Reco, Higher Price Target

Yahoo

time6 days ago

  • Business
  • Yahoo

PulteGroup (PHM) Snaps 3-Day Losses on Buy Reco, Higher Price Target

We recently published . PulteGroup, Inc. (NYSE:PHM) is one of Tuesday's top performers. PulteGroup snapped a three-day losing streak on Tuesday, jumping 11.52 percent to close at $121.17 apiece as investors took heart from an investment firm's rating and price target upgrade for its stock. In a market note, Seaport Global Securities raised its price target for PulteGroup, Inc. (NYSE:PHM) to $155, marking a 28-percent upside from its latest closing price. The brokerage also gave a 'buy' recommendation for its stock. The upgrade was based on PulteGroup, Inc.'s (NYSE:PHM) second quarter guidance, which affirmed a more favorable investment case for the company. In the second quarter of the year, PulteGroup, Inc. (NYSE:PHM) dropped its net income by 24.8 percent to $608 million from $809 million in the same period last year. Construction workers laying bricks during the residential development of multiple lots. Revenues also dipped by 4 percent to $4.4 billion from $4.59 billion year-on-year. Home sale gross margin stood at 27 percent, lower than the 29.9 percent last year, but was within the company's previously provided guidance. While we acknowledge the potential of PHM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio

PulteGroup Results Weaken as Housing Market Continues to Struggle
PulteGroup Results Weaken as Housing Market Continues to Struggle

Wall Street Journal

time22-07-2025

  • Business
  • Wall Street Journal

PulteGroup Results Weaken as Housing Market Continues to Struggle

PulteGroup PHM -0.01%decrease; red down pointing triangle saw results weaken in its latest quarter as fewer homes were purchased, reflecting a housing market that continues to struggle under the weight of low consumer confidence and challenging economic conditions. The results—while ahead of Wall Street's estimates—come as consumers have been locked out by higher home prices and elevated mortgage rates. More recent uncertainty brought on by tariff-related news chilled demand further, though the broader economy has largely held up.

PulteGroup: Q2 Earnings Snapshot
PulteGroup: Q2 Earnings Snapshot

Yahoo

time22-07-2025

  • Business
  • Yahoo

PulteGroup: Q2 Earnings Snapshot

ATLANTA (AP) — ATLANTA (AP) — PulteGroup Inc. (PHM) on Tuesday reported second-quarter net income of $608.5 million. On a per-share basis, the Atlanta-based company said it had net income of $3.03. The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.92 per share. The homebuilder posted revenue of $4.4 billion in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $4.37 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PHM at Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

How Will PulteGroup Stock React To Its Upcoming Earnings?
How Will PulteGroup Stock React To Its Upcoming Earnings?

Forbes

time18-07-2025

  • Business
  • Forbes

How Will PulteGroup Stock React To Its Upcoming Earnings?

POLAND - 2024/12/17: In this photo illustration, the PulteGroup company logo is seen displayed on a ... More smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images) PulteGroup (NYSE: PHM), an American home construction firm, is scheduled to announce its fiscal second-quarter earnings on Tuesday, July 22, 2025. Analysts anticipate that the company will deliver earnings of $3.01 per share along with $4.42 billion in revenue. This forecast reflects a 16% drop in adjusted earnings and a 4% decline in revenue compared to last year's figures of $3.58 per share and $4.60 billion, respectively. Historically, the stock has increased following earnings reports 70% of the time, showcasing a median one-day gain of 4.4% and a peak increase of 9%. PulteGroup's unit backlog fell by 16% year-over-year in Q1, with the backlog's value decreasing by 12%, indicating potential challenges for future revenue. Navigating this downturn in the face of heightened competition and economic pressures will be essential for maintaining growth in the upcoming quarters. The company currently boasts a market capitalization of $23 billion. Over the past twelve months, revenue was $18 billion, and it achieved operational profitability with $3.8 billion in operating profits and net income of $2.9 billion. While much will hinge on how results compare with consensus and predictions, grasping historical trends could favor you if you are a trader focused on events. For event-driven traders, historical data might provide a competitive edge, whether by positioning in advance of earnings or responding to post-release movements. If you are looking for opportunities with lower volatility than individual stocks, the Trefis High-Quality portfolio offers an alternative, having consistently outperformed the S&P 500 and delivered returns exceeding 91% since its inception. See earnings reaction history of all stocks. PulteGroup's Historical Odds Of Positive Post-Earnings Return Here are some insights into one-day (1D) post-earnings returns: Additional data on the observed 5-Day (5D) and 21-Day (21D) returns post earnings are consolidated along with the statistics in the table below. PHM 1D, 5D, and 21D Post Earnings Return Correlation Between 1D, 5D, and 21D Historical Returns A relatively lower-risk strategy (though less effective if the correlation is weak) involves understanding the correlation between short-term and medium-term returns following earnings announcements, identifying a pair with the highest correlation, and executing the appropriate trade. For instance, if 1D and 5D exhibit the strongest correlation, a trader can take a "long" position for the next 5 days if the 1D post-earnings return is positive. Here is some correlation data based on 5-year and what is now 3-year historical patterns. Note that the correlation 1D_5D indicates the relationship between 1D post-earnings returns and subsequent 5D returns. PHM Correlation Between 1D, 5D, and 21D Historical Returns Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all three indices: the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns for investors.

HIMSS25 APAC Highlights Surge in Population Health Tech Adoption Across Asia-Pacific, Recognizes Regional Leaders in Digital Health Innovation
HIMSS25 APAC Highlights Surge in Population Health Tech Adoption Across Asia-Pacific, Recognizes Regional Leaders in Digital Health Innovation

Yahoo

time18-07-2025

  • Health
  • Yahoo

HIMSS25 APAC Highlights Surge in Population Health Tech Adoption Across Asia-Pacific, Recognizes Regional Leaders in Digital Health Innovation

Asia-Pacific to Drive One-Third of Global PHM Market Growth, Projecting $89.3B by 2030 Amid Aging Demographics and Chronic Disease Challenges, Black Book Research KUALA LUMPUR, MY / / July 16, 2025 / As HIMSS25 APAC convenes healthcare leaders, innovators, and policymakers in Kuala Lumpur this week, a major spotlight is cast on the dramatic rise of Population Health Management (PHM) adoption across the Asia-Pacific region. According to the newly released Q3 2025 Black Book of Global Healthcare IT, Asia-Pacific is projected to account for 33% of global PHM market growth, reaching an estimated USD 90 billion by 2031. This growth is being driven by a convergence of strategic public health investments, demographic pressure from rapidly aging populations, rising chronic disease burdens, and aggressive digital health policies in countries such as Australia, China, Japan, India, and South Korea. These developments are fueling demand for PHM software, analytics, and care coordination tools that enable smarter, more equitable healthcare delivery. The 540-page Black Book report underscores how Asia-Pacific nations are embracing PHM technologies to modernize fragmented systems, prioritize preventive care, and advance health equity across urban and rural populations. HIMSS25 APAC celebrates this transformation by recognizing the region's top-rated PHM vendors named through surveys of healthcare professionals worldwide across 110 countries for their leadership in accelerating digital health progress. PHM Innovation Driving National Digital Health Strategies Across the Asia-Pacific region, national health systems are undergoing a structural shift toward data-driven, interoperable ecosystems, with Population Health Management platforms emerging as core enablers of healthcare modernization. Governments are embedding PHM strategies into national digital health roadmaps to manage epidemiological transitions, optimize longitudinal care, and mitigate systemic inefficiencies through predictive analytics and real-time data integration. Japan is deploying scalable PHM frameworks to support its super-aged society as 36.2% of its population will be over 65 by 2030. The Ministry of Health, Labour and Welfare (MHLW) is accelerating investments in integrated care networks, leveraging AI-assisted telehealth systems and health information exchange (HIE) platforms to enable proactive chronic disease surveillance, care coordination, and eldercare continuity across prefectures. South Korea is integrating population health analytics into its National Health Insurance Service (NHIS) and national precision medicine roadmap. Government-led initiatives like the "Data Dam" project are fueling cross-sector PHM innovation, with over 45 million citizens' clinical and claims data being securely harnessed for AI-driven risk stratification, early intervention modeling, and population-level disease forecasting. China, under the Healthy China 2030 framework, has made PHM a strategic priority. With over 260 million citizens living with chronic illnesses, China has invested in more than 1,800 "smart hospital" pilots across provinces. These facilities incorporate real-time PHM dashboards, regional health data lakes, and cloud-based chronic disease registries, supporting large-scale risk analytics and personalized preventive care strategies. India is rapidly scaling its digital public infrastructure (DPI) through the Ayushman Bharat Digital Mission (ABDM), targeting over 1.4 billion citizens. With World Bank and Asian Development Bank support exceeding $1.3B, India is integrating PHM tools into its national health stack, linking EHRs, citizen health IDs, and national analytics grids to drive population-wide surveillance, immunization tracking, and digital therapeutics in remote and underserved geographies. Australia continues to lead in rural and remote care innovation, supported by the National Digital Health Strategy and the My Health Record expansion. Through advanced telehealth integration, real-time care planning platforms, and federated PHM solutions, Australia is enhancing access for its 7 million rural residents. The Australian Digital Health Agency has reported a 52% increase in digitally coordinated chronic care encounters since 2022, largely attributed to targeted PHM deployments. Top-Ranked Population Health Vendors in Asia-Pacific: Performance Deep Dive Dedalus Markets: Australia, JapanDedalus is recognized for its advanced care coordination frameworks and analytics engines that align with national health strategies. In Australia, Dedalus powers PHM modules integrated into state-wide digital health programs, such as the Single Digital Patient Record initiative. In Japan, Dedalus supports regional health information exchange (HIE) networks, enabling seamless clinical data aggregation and longitudinal care tracking in compliance with the Japanese Medical Information System Development Center (MEDIS-DC) standards. Users report high marks for multi-lingual UI adaptability, interoperability with national eHealth records, and care pathway analytics, especially in managing cardiovascular and diabetic populations. __________ GuidelineX Markets: Australia, New Zealand, Southeast AsiaGuidelineX's AI-driven clinical decision support tools are especially lauded by public and private health systems implementing predictive care models. Southeast Asia deployments, including in Singapore and Thailand, showcase GuidelineX's natural language processing (NLP)-driven population stratification tools that integrate with low-resource environments and diverse clinical vocabularies. Black Book respondents highlight its real-time predictive insights and clinician workflow integration as key differentiators. __________ iMedway Markets: China, ASEAN (Vietnam, Malaysia, Indonesia)iMedway's strength lies in scalable, federated data platforms tailored to diverse public health ecosystems. In China, iMedway's PHM modules are embedded in 20+ provincial health bureaus' disease management registries, supporting over 90 million patient records and real-time epidemiological analytics under the National Health Commission framework. In ASEAN, iMedway is being adopted in urban/rural public-private integration pilots. In Malaysia, for example, the firm supports the MyHealth Analytics Hub, noted for automated patient segmentation and decentralized data access. Users praise iMedway for low-latency data warehousing and FHIR-native APIs, enabling plug-and-play with existing EMRs and national HIS networks. __________ InterSystems Markets: Australia, Japan, Greater APACInterSystems is a top performer for its unified health information platforms with embedded PHM tools and semantic interoperability. Its HealthShare solution underpins regional eHealth infrastructures, such as South Australia's statewide care coordination platform, which integrates data from over 120 hospitals and GP practices. In Japan, InterSystems supports PHM analytics aligned with national long-term care and chronic disease models, with high performance scores in data harmonization and HL7/FHIR conformance. Clients across APAC report InterSystems leads in real-time population dashboards, integrated care record access, and clinical outcomes tracking. __________ IQVIA Markets: China, Japan, South Korea, AustraliaKnown globally for real-world data and advanced analytics, IQVIA's Asia-Pacific PHM tools are used extensively in value-based care pilots and life sciences partnerships. In South Korea, IQVIA partners with the NHIS on nationwide population analytics, using de-identified claims and genomics data to guide cancer and rare disease programs. In Australia and Japan, IQVIA supports payer-provider collaborations focused on risk-adjusted benchmarking and clinical pathway optimization, with users citing high confidence in its data quality, multi-source integration, and AI model transparency. __________ Milliman Markets: Japan, India, China, South KoreaMilliman's actuarial-driven PHM analytics tools are highly regarded in markets prioritizing cost containment and risk pool optimization. In India, Milliman supports state-based insurance schemes under Ayushman Bharat by enabling prospective cost modeling and hospital utilization pattern analytics. In China and Japan, Milliman's tools are used to simulate public health scenarios and resource allocation, especially in population risk pooling and bundled payment planning. __________ Oracle Health Markets: Australia and broader APACOracle Health (formerly Cerner) remains a top-tier PHM platform provider across large health systems and government programs. In Australia, Oracle Health powers major PHM deployments in the public hospital system, particularly in Victoria and Queensland, where its solutions support integrated chronic disease pathways, social determinants of health (SDoH) risk indexing, and automated alerts for at-risk populations. The platform is praised for scalability, robust data governance tools, and strong integration with AI-powered clinical decision tools post-Oracle acquisition. __________ Orion Health Markets: Australia, New Zealand, Asia-PacificOrion Health continues to lead in interoperability-centric PHM deployments across Oceania. Its Amadeus platform is widely adopted in New Zealand's national electronic health record system and by Local Health Networks in Australia, offering cross-provider care plans, real-time patient summaries, and predictive analytics. Clients rate Orion highly for FHIR-native architecture, intuitive clinician dashboards, and strong patient engagement modules in community care environments. __________ Telstra Health Markets: AustraliaTelstra Health remains a domestic leader in PHM for chronic disease management and virtual care enablement. Through partnerships with state and territory governments, Telstra Health supports remote patient monitoring, telehealth-based care plans, and analytics for Aboriginal and Torres Strait Islander populations, contributing to improved access and outcome tracking in remote communities. Its tools are noted for interoperability with national repositories (e.g., My Health Record) and alignment with national PHM metrics. "The Asia-Pacific region is rapidly becoming a global benchmark for population health innovation," said Doug Brown, Founder of Black Book Research. "Strategic investments and coordinated national policies are accelerating digital transformation and enabling scalable care improvements. Governments, regional health systems, and private networks are aligning on shared PHM goals." For instance, China's Healthy China 2030 initiative aims to connect more than 75% of hospitals to PHM-capable infrastructure within five years. South Korea's government-backed health data integration programs are empowering precision public health. Meanwhile, India's digital health roadmap is targeting rural and underserved populations with scalable, cloud-enabled PHM tools. About Black Book Research:Black Book Research is the healthcare industry's leading independent research firm, known for amplifying the voices of frontline users, clinicians, and technology stakeholders across 110 countries. Its annual Population Health Yearbook and Global HIT Insights reports provide decision-makers with unbiased intelligence on digital health transformations, platform performance, and real-world adoption. The Q3 updated Black Book study gathered perspectives from 151 senior officials and executives across APAC, highlighting not just adoption momentum, but measurable impacts on care outcomes, resource planning, and health equity. Media Contact: research@ Download the report at no charge to industry stakeholders globally at Contact Information Press Office research@ SOURCE: Black Book Research View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store